Lateral Flow Assays Market– Growth Rate, opportunities, and Forecast 2027

The Lateral Flow Assays industry is expected to grow significantly in the near future due to the increasing demand for rapid, portable, and easy-to-use diagnostic tests

The Global Lateral Flow Assays Market in terms of revenue was estimated to be worth $20.5 billion in 2022 and is poised to reach $22.6 billion by 2027, growing at a CAGR of 2.0% from 2022 to 2027.

Increasing adoption of kits reagents and lateral flow assay readers for infectious diseases testing, veterinary diagnostics, and drug of abuse testing, cardiac marker testing. Whereas most of lateral flow assays are having limitation of qualitative detection, lot to lot variation like factors may hinder the growth of global market during the forecast period.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167205133

Browse in-depth TOC on "Lateral Flow Readers Industry"

366 - Tables

58 - Figures

374 – Pages

"Lateral Flow Readers segment is expected to witness the fastest growth during the forecast period"

Based on product type, the lateral flow assays market is segmented into kits reagents and lateral flow readers. During the forecast period, this segment is expected to witness the fastest growth during the forecast period. The factors responsible for the growth of this segment are increasing demand of quantitative analysis of clinical sample.

"Veterinary Diagnostics segment accounted for the second largest share of lateral flow assays market in 2021"

Based on applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety environmental testing, and drug development quality testing. The veterinary diagnostics segment accounted for the second largest share of the lateral flow assays market in 2021. The possibility of infectious disease outbreaks (particularly in large livestock animals) is driving the demand for lateral flow tests due to their simplicity and rapidity compared to conventional detection methods.

"Multiplex Detection Assays technique is expected to witness the fastest growth during the forecast period"

Based on technique, the lateral flow assay kits reagents market is segmented into competitive assays, sandwich assays, and multiplex detection assays. The multiplex detection assays technique is expected to witness the fastest growth during the forecast period. The widening scope, applications, and research on multiplex detection assays are expected to boost the growth of this segment in the forecast period.

The lateral flow assays market is segmented into five regions namely North America, Europe, Asia-Pacific, Latin America, and Middle East Africa. Asia-Pacific is the second largest region along with fastest growing region of lateral flow assays market owing to major investments in rapid testing in this region.

Request Free Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=167205133

Lateral Flow Assays Industry Dynamics:

Drivers:

  • High prevalence of infectious diseases across the globe
  • Rapidly increasing geriatric population
  • Growing usage of home-based lateral flow assay devices
  • Growing demand for point-of-care testing
  • Need for rapid diagnostic testing for COVID-19

Restraints:

  • Inconsistent results of lateral flow assay tests

Opportunities:

  • Evolving applications of lateral flow assays

Rising demand for lateral flow assays in the food beverage industry

  1. Omicron – The new variant of concern is an opportunity for the lateral flow assays market
  2. Government initiatives for omicron
  3. Initiatives of Medical diagnostic companies for omicron

Challenges:

  • Limited reimbursements for lateral flow assay products
  • Difficulties in procuring quality raw materials for the development of lateral flow assay tests

Key Market Players:

The prominent players in the global lateral flow assays market include Abbott Laboratories (US), Quidel Corporation (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), and Merck KGaA (Germany).

Recent Developments:

  • In October 2022, F. Hoffmann-La Roche Ltd. (Switzerland) a next-generation portfolio of SARS-CoV-2 rapid antigen test 2.01, SARS-CoV-2 Rapid Antigen Test 2.0 Nasal2, and SARS-CoV-2 Rapid Antigen Test 2.0 Nasal3
  • In June 2021, Abbott Laboratories (US) received the CE approval for PanBio Rapid Antigen Self-test, opening access throughout Europe to fast, reliable COVID-19 testing

Frequently Asked Questions (FAQs):

  • What is the projected market value of the global lateral flow assays market?
  • What is the estimated growth rate (CAGR) of the global lateral flow assays market for the next five years?
  • What are the major revenue pockets in the lateral flow assays market currently?

Speak to Analyst:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=167205133

 About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: [email protected]

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/lateral-flow-assay-market.asp

Visit Our Website: https://www.marketsandmarkets.com/

Content Source: https://www.marketsandmarkets.com/PressReleases/lateral-flow-assay.asp


Healthcare101

248 Blog posts

Comments